Literature DB >> 7711505

Thyroid peroxidase in dyshormonogenetic goiters with organification and thyroglobulin defects.

D P de Carvalho1, K G Rego, D Rosenthal.   

Abstract

Thyroid peroxidase (TPO) iodide and guaiacol oxidation activities were evaluated in eight dyshormonogenetic goiters. Two of these had a defective thyroglobulin; the TPO iodide oxidation (431 and 316 U/g ptn) and iodination (31 and 8.6 nmol I/mg ptn) activities were within the normal ranges. The goiters from two siblings with positive perchlorate iodide discharge tests also had normal TPO iodide oxidation (602 and 299 U/g ptn) and iodination activities (44 and 11 nmol I/mg ptn). No TPO iodide oxidation activity was found in the goiters from the other four patients with positive perchlorate iodide discharge tests, and TPO iodide oxidation inhibitory activities were detected in both their TPO and thyroglobulin preparations. Three of them had some TPO guaiacol oxidation activity and did not inhibit normal guaiacol oxidation. The TPO preparation immunoblot of these three goiters showed a faintly visible band of normal 100 kDa TPO. However, in the other patient no guaiacol oxidation activity was detected, and only two bands of low-molecular-weight TPO (72 and 43 kDa) were found, again showing that iodine organification defects in dyshormonogenetic goiters can be due to either qualitative or quantitative TPO defects. The TPO inhibition diminished when iodide was increased in the assay, but was not altered by increasing cofactor (H2O2). Our results, so far, suggest that the TPO-inhibitory substance may interact reversibly with a specific iodide site on the enzyme or with the oxidized form of iodide, and/or could bind free iodide, making it unavailable for enzymatic oxidation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7711505     DOI: 10.1089/thy.1994.4.421

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  2 in total

1.  Flavonoid rutin increases thyroid iodide uptake in rats.

Authors:  Carlos Frederico Lima Gonçalves; Carlos Frederico Lima Gonçalves; Maria Carolina de Souza dos Santos; Maria Carolina de Souza dos Santos; Maria Gloria Ginabreda; Rodrigo Soares Fortunato; Rodrigo Soares Fortunato; Denise Pires de Carvalho; Denise Pires de Carvalho; Andrea Claudia Freitas Ferreira
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

2.  Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.

Authors:  Alvaro Souto Padron; Ruy Andrade Louzada Neto; Thiago Urgal Pantaleão; Maria Carolina de Souza dos Santos; Renata Lopes Araujo; Bruno Moulin de Andrade; Monique da Silva Leandro; João Pedro Saar Werneck de Castro; Andrea Claudia Freitas Ferreira; Denise Pires de Carvalho
Journal:  J Endocrinol       Date:  2014-04-01       Impact factor: 4.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.